Felice Mucilli

<i>EGFR</i> Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment

Antonio Marchetti, Carla Martella, Lara Felicioni et al. · Journal of Clinical Oncology · 2005 · 793 citations

Medicine, Genetics, Oncology +17

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring <i>BRAF</i> Mutations

Antonio Marchetti, Lara Felicioni, Sara Malatesta et al. · Journal of Clinical Oncology · 2011 · 561 citations

Medicine, Genetics, Oncology +17

Mutational analysis of the <i>HER2</i> gene in lung tumors from Caucasian patients: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features

Fiamma Buttitta, Fabio Barassi, Giuseppina Fresu et al. · International Journal of Cancer · 2006 · 175 citations · Full text

Medicine, Genetics, Oncology +16

ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm

Antonio Marchetti, Alessia Di Lorito, Maria Vittoria Pace et al. · Journal of Thoracic Oncology · 2016 · 125 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.

Antonio Marchetti, Nicola Tinari, Fiamma Buttitta et al. · PubMed · 2002 · 117 citations

Medicine, Oncology, Pathology +17